The rising interest in effective weight management has led to considerable exploration into groundbreaking treatments. Lately , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor agonist , has demonstrated encouraging results in medical trials, suggesting potential for substantial weight loss . Conseq